Zogenix (ZGNX) Surges Despite PDUFA Delay; Analysts View Positively
Tweet Send to a Friend
Zogenix, Inc. (NASDAQ: ZGNX) sees sharp upside despite a FDA PDUFA delay on Zohydro.
After the close, Zogenix said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
After the close, Zogenix said ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
